These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Corbin JD; Francis SH; Webb DJ Urology; 2002 Sep; 60(2 Suppl 2):4-11. PubMed ID: 12414329 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859. Qiu Y; Bhattacharjee S; Kraft P; John TM; Craig E; Haynes-Johnson D; Guan J; Jiang W; Macielag M; Sui Z; Clancy J; Lundeen S Eur J Pharmacol; 2003 Jul; 472(1-2):73-80. PubMed ID: 12860475 [TBL] [Abstract][Full Text] [Related]
28. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347 [TBL] [Abstract][Full Text] [Related]
29. Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: potential agents for treatment of erectile dysfunction. Yu G; Mason HJ; Wu X; Wang J; Chong S; Dorough G; Henwood A; Pongrac R; Seliger L; He B; Normandin D; Adam L; Krupinski J; Macor JE J Med Chem; 2001 Mar; 44(7):1025-7. PubMed ID: 11297448 [No Abstract] [Full Text] [Related]
30. Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases. Wang P; Wu P; Myers JG; Stamford A; Egan RW; Billah MM Life Sci; 2001 Mar; 68(17):1977-87. PubMed ID: 11388700 [TBL] [Abstract][Full Text] [Related]
31. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum. Qiu Y; Kraft P; Lombardi E; Clancy J J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172 [TBL] [Abstract][Full Text] [Related]
32. A solid-phase approach towards the synthesis of PDE5 inhibitors. Beer D; Bhalay G; Dunstan A; Glen A; Haberthuer S; Moser H Bioorg Med Chem Lett; 2002 Aug; 12(15):1973-6. PubMed ID: 12113821 [TBL] [Abstract][Full Text] [Related]
33. 1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor. Ukita T; Nakamura Y; Kubo A; Yamamoto Y; Takahashi M; Kotera J; Ikeo T J Med Chem; 1999 Apr; 42(7):1293-305. PubMed ID: 10197972 [TBL] [Abstract][Full Text] [Related]
34. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Morelli A; Filippi S; Mancina R; Luconi M; Vignozzi L; Marini M; Orlando C; Vannelli GB; Aversa A; Natali A; Forti G; Giorgi M; Jannini EA; Ledda F; Maggi M Endocrinology; 2004 May; 145(5):2253-63. PubMed ID: 14764637 [TBL] [Abstract][Full Text] [Related]
35. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. Kassim AA; Fabry ME; Nagel RL Blood; 2000 Mar; 95(5):1878-9. PubMed ID: 10744389 [No Abstract] [Full Text] [Related]
36. Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule. Bunnage ME; Mathias JP; Wood A; Miller D; Street SD Bioorg Med Chem Lett; 2008 Dec; 18(23):6033-6. PubMed ID: 18951784 [TBL] [Abstract][Full Text] [Related]
37. Relaxation effect of nitric oxide-donor on diabetic penile smooth muscle in vitro. Taher A; Birowo P; Kamil ST; Shahab N Clin Hemorheol Microcirc; 2000; 23(2-4):277-81. PubMed ID: 11321451 [TBL] [Abstract][Full Text] [Related]
38. A novel compound JPM8: in vivo penile activity promotion in rats, effect on the relaxation and cGMP/cAMP accumulation in isolated rabbit corpora cavernosa. El-Thaher TS; Khatib S; Saleem M; Shnoudeh A; Badwan AA Int J Impot Res; 2002 Dec; 14(6):453-61. PubMed ID: 12494277 [TBL] [Abstract][Full Text] [Related]
39. The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5. Wallis RM Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():22P-26P. PubMed ID: 10629850 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension. Watanabe H Intern Med; 2004 Oct; 43(10):891-3. PubMed ID: 15575233 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]